bwb as far as i can tell of the deals you refer to Le Mertier...

bwb as far as i can tell of the deals you refer to Le Mertier was never one of the major deals. Wasnt that just the license deal that may or may not one day produce cash when the cosmetic product goes to market. Of the four major pharma deals Janssen is obviously still in play. The last yearly report mentioned specifically that Pfizer deal had progressed, so even without update something must still be happening with that deal. The Roche and Meddimune deals appear to be dead in the water at the moment.
Potential right at this moment appears to be a possible license with Janssen atound year end, and assuming pfizer is still active then surely they must be getting close to some sort if milestone or result.

The biggest problem here seems to be the fact that they refuse to give any updates on existing deals other than Janssen, and refuse to give information or updates on other deal negotiations. The second item woukdnt be such a big deal if they didnt keep saying they are having i.terest or netotiations with various potential leads. This may actually be causing a lot of damage to their imafe as from whete im sitting these statements indicate that a lot of clever people are talking to pyc and then saying no thanks. Best hope from market info is that current cash and tax break can get them to a license deal with janssen. Even then, are we talking millions or just another 600-800 k deal